Roche Holding AG
SIX:ROG

Watchlist Manager
Roche Holding AG Logo
Roche Holding AG
SIX:ROG
Watchlist
Price: 255.4 CHF 1.47% Market Closed
Market Cap: 206.7B CHF

P/E
Price to Earnings

17.7
Current
17.7
Median
19.8
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
17.7
=
Market Cap
203.6B CHF
/
Net Income
11.5B CHF
Market Cap P/E
CH
Roche Holding AG
SIX:ROG
203.6B CHF 17.7
US
Eli Lilly and Co
NYSE:LLY
715B USD 67.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
US
Johnson & Johnson
NYSE:JNJ
369.9B USD 26.3
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 18.7
CH
Novartis AG
SIX:NOVN
182.6B CHF 18.7
UK
AstraZeneca PLC
LSE:AZN
159.4B GBP 29.9
US
Merck & Co Inc
NYSE:MRK
197.1B USD 11.5
IE
Endo International PLC
LSE:0Y5F
162.4B USD -55.5
FR
Sanofi SA
PAR:SAN
114.3B EUR 19.9
US
Pfizer Inc
NYSE:PFE
126.9B USD 15.8
Earnings Growth PEG
CH
Roche Holding AG
SIX:ROG
Average P/E: 25.1
17.7
16%
1.1
US
Eli Lilly and Co
NYSE:LLY
67.5
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
26.3
26%
1
DK
Novo Nordisk A/S
CSE:NOVO B
18.7
19%
1
CH
Novartis AG
SIX:NOVN
18.7
16%
1.2
UK
AstraZeneca PLC
LSE:AZN
29.9
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.5
18%
0.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -55.5 N/A N/A
FR
Sanofi SA
PAR:SAN
19.9
28%
0.7
US
Pfizer Inc
NYSE:PFE
15.8
29%
0.5

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
13.3
2-Years Forward
P/E
12
3-Years Forward
P/E
11.3